Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Immunotherapy. Chiba University, Chiba, Japan

Survival: 18.6 months
Toxicity Grade: 3
Treatments: Immunotherapy
Country: Japan
City/State/Province: Chiba
Hospital: Chiba University
Journal: Link
Date: 2/2009

Patients: This study involved 17 patients with advanced and recurrent non-small cell lung cancer. There were five women and twelve men, ranging in age from 43 to 73 years.

Treatment: Patients were treated with immunotherapy, where some immune system cells (called peripheral blood mononuclear cells) were collected from their blood and then combined with a mixture designed to “activate” them. Then, the cells are put back into the patients body.

Toxicity: One patient experienced grade 3 deep vein thrombosis. There were six reports of grade 2 toxicities, which included fever, anemia, and bloody sputum.

Results: The median overall survival was 18.6 months.

Correspondence: Dr. Toshinori Nakayama

E-mail to a Friend Email Physician More Information